• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名七岁儿童的纯合子家族性高胆固醇血症:一项强调早期诊断重要性的病例研究

Homozygous Familial Hypercholesterolemia in a Seven-Year-Old: A Case Study Highlighting the Importance of Early Diagnosis.

作者信息

Bensabbahia Dalal, El Achiwi Meriem, Atrassi Meriem, Abkari Abdelhak, Widad Gueddari

机构信息

Department of Pediatrics 3, Pediatric Gastroenterology and Hepatology Unit, Abderrahim Harouchi Mother and Child Hospital, Ibn Rochd University Hospital, Casablanca, MAR.

Department of Pediatric Emergency Medicine, Abderrahim Harouchi Mother and Child Hospital, Ibn Rochd University Hospital, Casablanca, MAR.

出版信息

Cureus. 2025 Jun 17;17(6):e86219. doi: 10.7759/cureus.86219. eCollection 2025 Jun.

DOI:10.7759/cureus.86219
PMID:40677483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12269912/
Abstract

Familial hypercholesterolemia (FH) is a common autosomal dominant disorder characterized by markedly elevated low-density lipoprotein (LDL)-cholesterol levels and an increased risk of premature cardiovascular disease. The homozygous form, which is much rarer and more severe, manifests in early childhood with extremely high LDL-cholesterol levels and early-onset atherosclerosis. We report the case of a seven-year-old girl, born to consanguineous parents, presenting with tuberous and tendinous xanthomas. Her lipid profile revealed severe hypercholesterolemia (total cholesterol: 7.5 g/L; LDL-C: 6.82 g/L), low high-density lipoprotein-cholesterol (HDL-C) (0.29 g/L), and normal triglycerides. Echocardiography showed atheromatous lesions in the aortic arch. Molecular analysis identified a pathogenic homozygous mutation in the LDLR gene. Treatment with atorvastatin followed by ezetimibe was initiated, along with dietary and lifestyle modifications. Follow-up showed moderate regression of the atheromatous lesions. A six-month follow-up plan was established, and LDL apheresis was considered. This case highlights the importance of early screening, genetic confirmation, and intensive multidisciplinary management to prevent premature cardiovascular complications in children with homozygous familial hypercholesterolemia.

摘要

家族性高胆固醇血症(FH)是一种常见的常染色体显性疾病,其特征为低密度脂蛋白(LDL)胆固醇水平显著升高以及早发性心血管疾病风险增加。纯合子形式更为罕见且病情更严重,在儿童早期表现为极高的LDL胆固醇水平和早发性动脉粥样硬化。我们报告了一例七岁女孩的病例,其父母为近亲结婚,患儿出现结节性和肌腱性黄色瘤。她的血脂谱显示严重高胆固醇血症(总胆固醇:7.5 g/L;LDL-C:6.82 g/L)、低高密度脂蛋白胆固醇(HDL-C)(0.29 g/L)且甘油三酯正常。超声心动图显示主动脉弓有动脉粥样硬化病变。分子分析在LDLR基因中鉴定出一个致病性纯合突变。开始使用阿托伐他汀随后加用依折麦布进行治疗,并同时进行饮食和生活方式调整。随访显示动脉粥样硬化病变有中度消退。制定了为期六个月的随访计划,并考虑进行LDL血液成分分离术。该病例强调了早期筛查、基因确诊以及强化多学科管理对于预防纯合子家族性高胆固醇血症患儿过早出现心血管并发症的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/1e4f3c2e9500/cureus-0017-00000086219-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/050b75351072/cureus-0017-00000086219-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/11544bf524a3/cureus-0017-00000086219-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/9e1eb5a47ce5/cureus-0017-00000086219-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/6fc21ae695f9/cureus-0017-00000086219-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/dc410278364c/cureus-0017-00000086219-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/1e4f3c2e9500/cureus-0017-00000086219-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/050b75351072/cureus-0017-00000086219-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/11544bf524a3/cureus-0017-00000086219-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/9e1eb5a47ce5/cureus-0017-00000086219-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/6fc21ae695f9/cureus-0017-00000086219-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/dc410278364c/cureus-0017-00000086219-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf13/12269912/1e4f3c2e9500/cureus-0017-00000086219-i06.jpg

相似文献

1
Homozygous Familial Hypercholesterolemia in a Seven-Year-Old: A Case Study Highlighting the Importance of Early Diagnosis.一名七岁儿童的纯合子家族性高胆固醇血症:一项强调早期诊断重要性的病例研究
Cureus. 2025 Jun 17;17(6):e86219. doi: 10.7759/cureus.86219. eCollection 2025 Jun.
2
Familial Hypercholesterolemia家族性高胆固醇血症
3
Statins for children with familial hypercholesterolemia.用于患有家族性高胆固醇血症儿童的他汀类药物。
Cochrane Database Syst Rev. 2017 Jul 7;7(7):CD006401. doi: 10.1002/14651858.CD006401.pub4.
4
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.脂蛋白吸附治疗起始于儿童期的纯合子家族性高胆固醇血症患者的心血管结局:来自两个登记处的国际队列的长期随访。
Lancet Child Adolesc Health. 2024 Jul;8(7):491-499. doi: 10.1016/S2352-4642(24)00073-7. Epub 2024 May 14.
5
Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective-Brief Report.依维单抗在纯合子家族性高胆固醇血症儿童和成人中的真实世界有效性和安全性:美国多中心视角——简要报告
Arterioscler Thromb Vasc Biol. 2025 Jul;45(7):1310-1315. doi: 10.1161/ATVBAHA.124.322364. Epub 2025 May 29.
6
Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial.inclisiran治疗基因确诊的纯合子家族性高胆固醇血症青少年的疗效和安全性:ORION-13随机试验双盲、安慰剂对照部分的结果
Circulation. 2025 Jun 24;151(25):1758-1766. doi: 10.1161/CIRCULATIONAHA.124.073233. Epub 2025 May 20.
7
AAV8- Gene Therapy in -KO and Homozygous p.W483X Mice.AAV8基因疗法在基因敲除和纯合p.W483X小鼠中的应用
Hum Gene Ther. 2025 Jul;36(13-14):976-988. doi: 10.1089/hum.2024.164. Epub 2025 Jun 4.
8
Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.儿童和青少年血脂筛查以发现家族性高胆固醇血症:美国预防服务工作组的证据报告和系统评价。
JAMA. 2016 Aug 9;316(6):645-55. doi: 10.1001/jama.2016.6176.
9
A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab.PCSK9 抑制剂依洛尤单抗和阿利西尤单抗的系统评价
J Manag Care Spec Pharm. 2016 Jun;22(6):641-653q. doi: 10.18553/jmcp.2016.22.6.641.
10
Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.家族性高胆固醇血症变异型与胆固醇升高个体的心血管风险。
JAMA Cardiol. 2024 Mar 1;9(3):263-271. doi: 10.1001/jamacardio.2023.5366.

本文引用的文献

1
Integrated guidance to enhance the care of children and adolescents with familial hypercholesterolaemia: Practical advice for the community clinician.综合指导以加强家族性高胆固醇血症患儿和青少年的照护:社区临床医生的实用建议。
J Paediatr Child Health. 2022 Aug;58(8):1297-1312. doi: 10.1111/jpc.16096. Epub 2022 Jul 15.
2
Guidance for Pediatric Familial Hypercholesterolemia 2017.2017 年儿童家族性高胆固醇血症治疗指南
J Atheroscler Thromb. 2018 Jun 1;25(6):539-553. doi: 10.5551/jat.CR002. Epub 2018 Feb 6.
3
Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
儿童-父母家族性高胆固醇血症的初级保健筛查。
N Engl J Med. 2016 Oct 27;375(17):1628-1637. doi: 10.1056/NEJMoa1602777.
4
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.儿童和青少年家族性高胆固醇血症:通过优化检测与治疗延长数十年寿命
Eur Heart J. 2015 Sep 21;36(36):2425-37. doi: 10.1093/eurheartj/ehv157. Epub 2015 May 25.
5
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.纯合子家族性高胆固醇血症:临床医生提高检测和临床管理水平的新见解与指南。欧洲动脉粥样硬化学会家族性高胆固醇血症共识小组的立场文件。
Eur Heart J. 2014 Aug 21;35(32):2146-57. doi: 10.1093/eurheartj/ehu274. Epub 2014 Jul 22.
6
PCSK9: a key modulator of cardiovascular health.PCSK9:心血管健康的关键调节因子。
Circ Res. 2014 Mar 14;114(6):1022-36. doi: 10.1161/CIRCRESAHA.114.301621.
7
Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.家族性高胆固醇血症纯合子:诊断与治疗的现状观点。
Atherosclerosis. 2012 Aug;223(2):262-8. doi: 10.1016/j.atherosclerosis.2012.02.019. Epub 2012 Feb 16.
8
Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.儿童和青少年心血管健康与风险降低综合指南专家小组:总结报告
Pediatrics. 2011 Dec;128 Suppl 5(Suppl 5):S213-56. doi: 10.1542/peds.2009-2107C. Epub 2011 Nov 14.
9
[Recommendations for children with hypercholesterolemia].[高胆固醇血症儿童的建议]
Arch Pediatr. 2011 Feb;18(2):217-29. doi: 10.1016/j.arcped.2010.10.017. Epub 2010 Dec 9.
10
[Dietary recommendations for children with hypercholesterolemia].[高胆固醇血症儿童的饮食建议]
Arch Pediatr. 2010 Jul;17(7):1126-32. doi: 10.1016/j.arcped.2010.04.014. Epub 2010 Jun 3.